Recruiting

Metabolomics in the Diagnosis and Treatment of Asthma in Children

The goal of this observational study is to learn about the metabolomic profile of blood and urine in children 12-17 years with asthma. The main question it aims to answer is: • Are there metabolites in the blood and urine that are specific for asthma exacerbation? Participants already receive standard therapy as part of their regular medical care for asthma.

ClinicalTrials.gov IDNCT07280364

PhaseNot Applicable

Enrollment100

SponsorI.M. Sechenov First Moscow State Medical University

Age12 Years

SexALL

I'm interested View official listing

Conditions studied

Asthma

About this study

Interventions

Drug: Standart medical treatment — No intervention, patients will recieve standard medical treatment

Primary outcomes

inflammation biomarkers (baseline and 10 days)

Eligibility information

Inclusion Criteria: * Age from 12 to 17 years old * Confirmed diagnosis of asthma * Informed voluntary consent to participate in the study Exclusion Criteria: * age under 12 years * no established diagnosis of asthma * concomitant severe somatic, metabolic, and endocrine diseases * patient's withdrawal of informed consent

Study locations

I.M. Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia

Before you participate: Varda Clinical is an independent discovery tool, not the study sponsor or a medical provider. Eligibility can only be determined by the official study team. Discuss potential risks and benefits with a qualified healthcare professional.

Source: ClinicalTrials.gov. Record last refreshed by Varda Clinical: 2026-09-27.